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Summary
Recent research in neuroimaging has focused on assessing associations between genetic variants
that are measured on a genomewide scale and brain imaging phenotypes. A large number of works
in the area apply massively univariate analyses on a genomewide basis to find single nucleotide
polymorphisms that influence brain structure. In this paper, we propose using various dimen-
sionality reduction methods on both brain structural MRI scans and genomic data, motivated by
the Alzheimer’s Disease Neuroimaging Initiative (ADNI) study. We also consider a new multiple
testing adjustment method and compare it with two existing false discovery rate (FDR) adjust-
ment methods. The simulation results suggest an increase in power for the proposed method.
The real data analysis suggests that the proposed procedure is able to find associations between
genetic variants and brain volume differences that offer potentially new biological insights.
Key words: Distance covariance ; Genomewide association studies; Local false discovery rate; Multivariate
analysis; Neuroimaging analysis; Positive false discovery rate.
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1. Introduction
Advanced automated image processing techniques have allowed the assessment of the genetic
association with brain phenotypes for complex diseases, such as schizophrenia (Potkin et al.,
2009), and Alzheimer’s disease (Furney et al., 2010). In this work, we consider data from the
Alzheimer’s Disease Neuroimaging Initiative (ADNI) project (ADNI, 2003) consisting of genetic
variants encoded as single nucleotide polymorphisms (SNPs) across whole genome, and brain
volume size measured by tensor-based morphometry (TBM) based on structural magnetic reso-
nance imaging (MRI) scans. Specifically, TBM computes the volume of a local brain region in
a given subjects’ MRI relative to an average template image based on healthy subjects. Since
a signature of Alzheimer’s Disease (AD) is the thinning of cortical gray matter and an increase
of cerebral spinal fluid volume (particularly in the ventricles), TBM is sensitive to AD-related
changes through decreases in volume of the cortex, and increases in volume of the ventricles.
Therefore, the goal of this work is to find the genetic variants that result in change of brain
volumes.
Stein et al. (2010a) conducted a voxelwide and genomewide study using TBM maps from each
subject, where each voxel is evaluated with a regression at each SNP based on the SNP’s minor
allele count, and using demographic variables as features with quantitative trait as responses. In
their experiment, no significant loci were found after a false discovery rate based on the multiple
testing adjustment procedure at level 0.05. In a later study, Stein et al. (2010b) performed a
genomewide search on two brain phenotypes (temporal lobe and hippocampal volume) based on
the prior results from the literature. To investigate the associations, they collected an independent
sample for each phenotype and performed adjusted regression analysis on the baseline population.
Overall, two significantly associated SNPs were identified: rs10845840, located on chromosome
12 within an intron of the GRIN2B gene, and rs2456930, which is in an intergenic region of
(ADNI) database (adni.loni.ucla.edu).
Multiple Comparison Procedures for Neuroimaging Genomewide Association Studies 3
chromosome 15. Both SNPs were significantly associated with bilateral temporal lobe volume,
while no significant SNPs were found to have associations with hippocampal phenotype.
For any univariate approach to analysis, multiple testing procedures should be employed as
there are many statistical tests being considered simultaneously. A recent error quantity called
false discovery rate (FDR) was proposed for the multiple comparisons problem by Benjamini and Hochberg
(1995). Later, Storey (2002) and Storey (2003) defined the positive false discovery rate (pFDR)
that is the conditional expectation of false positive findings given at least one positive identifi-
cations has occurred, and also proposed a q-value algorithm to control the pFDR. Efron et al.
(2001b) defined a local false discovery rate (locfdr), a Bayesian version of FDR. For its estimation,
they fit a mixture model to a Gaussian transformation of the inverse cumulative distribution
of the p-values. To relate the frequentist and Bayesian versions of FDR, Efron et al. (2001b),
Efron et al. (2001a), and Storey (2002) proved that the FDR controlled by the Benjamini and
Hochberg procedure is equivalent to empirical Bayesian FDR given the rejection regions. Further-
more, Newton et al. (2003) proposed a hierarchical mixture of Gammas for the multiple compar-
isons problem and Muralidharan (2010) showed that the locfdr estimation controls FDR/pFDR
over the entire exponential distribution family.
The previously published ADNI analyses were able to find associated SNPs or genes that are
likely to be related to some specific voxels of the brain scans. However, neighboring structures
of the brain were not being considered, and this information could play an important role in
associations with disease risk. In this work, this issue is addressed by combining the neighboring
voxels into 119 regions based on the GSK CIC atlas (Tziortzi et al., 2011), and then the effects
on the regions are simultaneously assessed using the distance covariance statistic (Szekely et al.,
2007), which allows for inference on the relationship between a 119-dimensional multivariate
phenotype and a single SNP predictor across the entire genome.
We make two contributions to the analysis of the ADNI neuroimaging genomewide study.
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First, we utilize distance covariance for the analysis of genomewide association study. This frame-
work is able to establish the relationships between genomic variants and brain structural MRI
where the entire brain is a multivariate response. By considering a multivariate response vari-
able, we reduce the number of tests being done relative to an approach such as in Stein et al.
(2010a), which results in more powerful inference. Second, we propose a local fdr modeling al-
gorithm to address the multiplicity which is to fit a two-component mixture of Gammas on
the distance covariance statistics. One probabilistic output of this model is the local fdr. This
leads to a decision-theoretic rule for selecting significant SNPs that is related to the approach
of Newton et al. (2003). In the multiple testing step, we also evaluate two existing methods for
comparison. Based on our simulation studies and real data analysis using ADNI, experiments
show that the proposed method is able to control FDR at different α levels as well as provide
more powerful findings than Stein et al. (2010a)’s work. In addition, we also present the pathway
analysis based on our significant findings in the supplementary material, and show that the signif-
icant SNPs survived from our procedures provide signal enrichment functions through pathway
to AD from the Database for Annotation, Visualization and Integrated Discovery (DAVID).
2. Materials
Data used in the preparation of this article were obtained from the ADNI study (ADNI, 2003).
The SNP data and the TBM data from the ADNI study are processed by Paul Thompson’s
group, which are the same as those used in the previous studies (Stein et al., 2010a). For the sake
of completeness, we describe the genetic and imaging data preprocessing in the following section.
2.1 ADNI study
The ADNI was launched in 2003 by the National Institute on Aging (NIA), the National Institute
of Biomedical Imaging and Bioengineering (NIBIB), the Food and Drug Administration (FDA),
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private pharmaceutical companies and non-profit organizations, as a 60 million, 5- year public-
private partnership. The primary goal of ADNI has been to test whether serial MRI, positron
emission tomography (PET), other biological markers, and clinical and neuropsychological assess-
ment can be combined to measure the progression of mild cognitive impairment (MCI) and early
AD. Determination of sensitive and specific markers of very early AD progression is intended
to aid researchers and clinicians to develop new treatments and monitor their effectiveness, as
well as lessen the time and cost of clinical trials. The Principal Investigator of this initiative is
Michael W. Weiner, MD, VA Medical Center and University of California San Francisco. ADNI
is the result of efforts of many co-investigators from a broad range of academic institutions and
private corporations, and subjects have been recruited from over 50 sites across the U.S. and
Canada. The initial goal of ADNI was to recruit 800 subjects but ADNI has been followed by
ADNI-GO and ADNI-2. To date these three protocols have recruited over 1500 adults, ages 55
to 90, to participate in the research, consisting of cognitively normal older individuals, people
with early or late MCI, and people with early AD. The follow up duration of each group is
specified in the protocols for ADNI-1, ADNI-2 and ADNI-GO. Subjects originally recruited for
ADNI-1 and ADNI-GO had the option to be followed in ADNI-2. For up-to-date information,
see www.adni-info.org.
Of the 852 total subjects released by the ADNI dataset, the availabilities of both brain struc-
tural MRI and genetics records were found in 741 subjects. The data for these subjects are used
for our experiments, where the volumetric brain differences are assessed in 206 normal older
controls, 358 MCI subjects, and 177 AD patients.
2.2 Genetic analysis
ADNI released 620,901 SNPs using the Illumina 610 Quad array. SNPs that did not fulfil the
following quality control criteria were excluded: genotype call rate smaller than 95%, significant
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deviation from Hardy-Weinberg equilibrium where p-value < 5.7× 10−7, allele frequency smaller
than 0.10, and a quality control score of smaller than 0.15. After applying this list of quality
criteria, we obtain a total of 448,244 SNPs for the analysis. The number of SNPs measured on
each chromosome is in table 1 in our supplementary material.
2.3 Brain MRI scans
Three-dimensional T1-weighted baseline MRI scans were analyzed using TBM: a method for
representing structural differences between local brain regions and a template brain into a de-
formation field (Friston et al., 2004). The deformation field contains the information on relative
positions of different brain scans, while the local shapes (such as volumes, lengths and areas) are
encoded in the Jacobian matrix. Therefore, TBM can be used to recognize the local shape of brain
differences. The MRI scans were acquired at 58 different ADNI sites, all with 1.5T MRI scanners
using a sagittal 3D MP-RAGE sequence for across-site consistency (Jack et al., 2008). All images
were calibrated with phantom-based geometric corrections. The scans were linearly registered
with 9 parameters to the International Consortium for Brain Image template (Mazziotta et al.,
2001) to adjust for differences in brain position and scaling. Each subject’s MRI scan was regis-
tered against a template scan which is the average of all the healthy subjects (minimal deforma-
tion template), using a non-linear inverse-consistent elastic intensity-based registration method
(Leow et al., 2005). Furthermore, voxel size variation from registration is represented as the voxel
intensity, which is the volumetric difference between the subject and the reference template, cal-
culated from taking the determinant of the Jacobian matrix of the deformation fields. Finally,
each brain scan volume is down-sampled to 1/4 of its original size (using trilinear interpolation
to 4×4×4mm3), which results into 31, 622 total voxels per scan for faster experimental process-
ing. Similar to Stein et al. (2010a), we use the volumetric difference representation of MRI as the
quantitative measure of brain tissue volume difference for the genomewide association analysis.
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We explore genomewide associations with brain volume difference in terms of voxels; we also
perform the same analysis based on groups of voxels, which is the focus of this work. This region of
interests (ROIs) approach is a type of dimensionality reduction method that allows for information
on local neighborhoods of voxels to be pooled, and reduces possible noise that associates with
performing analysis using the entire brain voxels, we denote this as the region-wide study. In
order to conduct the experiment using 119 ROIs, we extracted voxels from each brain region, and
computed the average Jacobian scores (per region) that make up the 119 different brain regions
from the GSK CIC Atlas as shown in Fig. 1, which is based on the Harvard-Oxford atlas with
a 6-level hierarchy. To extract the corresponding voxels from each brain region in the atlas, we
used the FLIRT linear registration tool from FSL (Jenkinson and Smith (2001), Jenkinson et al.
(2002), Smith et al. (2004), and Woolrich et al. (2009)) in order to register the brain atlas to our
template scan. This allows us to extract voxels of different brain regions from the subject’s scan
and the registered atlas by direct comparison. We then used the average per-region Jacobian
scores from each of the 119 ROIs as the response into genomewide association.
3. Methods
3.1 Distance covariance
The work of distance covariance in Szekely et al. (2007) and Szekely and Rizzo (2009) is discussed
here. Let φX and φY be the characteristic functions of X and Y , where X ∈ R
p and Y ∈ Rq are
two random vectors from two arbitrary dimensions p and q, respectively. The distance covariance
dCov2(X,Y ) between random vectors X and Y is a non-negative value with finite first moments:
dCov2(X,Y ) = ‖φX,Y (x, y)− φX(x)φY (y)‖
2 (3.1)
=
∫
Rp+q
|φX,Y (x, y)− φX(x)φY (y)|
2w(x, y) dxdy,
where w(x, y) is a positive weight function for which the integral in Eq. (3.1) exists.
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The sample distance covariance estimator from Szekely et al. (2007) and Szekely and Rizzo
(2009) requires that there be no missing values among observationsXi’s and Yj ’s for i, j = 1, ..., n.
In order to relax this requirement, we propose a modified version by assuming the data is missing
completely at random (MCAR, Heitjan and Basu (1996)). Here, δ is defined as an indicator which
indicates if a variable is missing or present:
δk =
{
1, if variable k is present
0, if variable k is missing
. (3.2)
Adjusting the indicator δ for observations Xi’s and Yj ’s puts larger weights on observations with
no missing values and zero weight on observations with missing values. For i, j = 1, ..., n, Our
modified preliminary statistics according to Szekely et al. (2007) as A′ij = a
′
ij − a¯
′
i. − a¯′.j + a¯′..,
where
a′ij =
|Xi −Xj |pδiδj
P (δi = 1)P (δj = 1)
(3.3)
and
a¯′i. =
1
n
n∑
j
a′ij a¯
′.j =
1
n
n∑
i
a′ij a¯
′.. =
1
n2
n∑
i,j
a′ij .
Similarly, we define B′ij = b
′
ij − b¯
′
i. − b¯′.j + b¯′.. with its elements taking the same form as A
′
ij .
The modified sample distance covariance d˜Cov
2
n(X,Y ) is then given by d˜Cov
2
n(X,Y ) =
n−2
∑n
i,j A
′
ijB
′
ij . Having proposed a modified empirical distance covariance for situations where
missing values are present, we can study its asymptotic property under the independent assump-
tion. The expectation of a′ij in Eq. (3.3) is:
E(a′ij) = E
{
|Xi −Xj |pδiδj
p(δi = 1)p(δj = 1)
}
(3.4)
= E(|Xi −Xj |p)
and similarly, E(b′ij) = E(|Yi−Yj |q). Arguing as in Szekely et al. (2007), we have that if E|X |p <
∞ and E|Y |q <∞, then d˜Covn →a.s dCov. Consequently, it can be shown that
T = n× d˜Cov
2
n/T
′
2
→D Q, (3.5)
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where T ′
2
= n−2
∑n
i,j a
′
ijn
−2Σni,jb
′
ij and Q is a positive semidefinite quadratic form of centered
Gaussian random variables with E(Q) = 1. Szekely et al. (2007) proposed a permutation test
for hypothesis testing. However, the permutation scheme is extremely computationally expensive
when dealing with large scale data such as our genomewide association study. In terms of obtaining
p-values, we apply a Gamma approximation for inference on the distance covariance statistics
(Gretton et al., 2008), which is discussed in Section 3.2.
For comparison purposes, we also investigate the case of missing at random (MAR) for im-
puting the missing values using a publicly available software PLINK (PLINK, 2007). The results
from the genotype imputation are addressed in Section 5.
3.2 Multiple testing procedure
We now review the multiple testing problem and define FDR. Assume that there are m tests
for the study, the goal is to identify the significant SNPs at a certain α level. Table 1 shows the
possible outcomes of conducting m tests simultaneously, for which the null hypothesis is true in
m0 of them. Of the m tests of hypotheses,W hypotheses are failed to be rejected, and R rejected
the null hypothesis.
Benjamini and Hochberg (1995) introduced a new measure called FDR, defined as:
FDR = E
[
V
R
|R > 0
]
P (R > 0) (3.6)
Storey (2002) and Storey (2003) proposed another measure, positive false discovery rate (pFDR),
which is the expected false-positive rate conditioned on positive finding (P (R = 0) > 0). The
pFDR takes the following form:
pFDR = E
[
V
R
|R > 0
]
(3.7)
Our aim is to control pFDR, and we present three algorithms to achieve this goal for the remainder
of this section.
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The first algorithm is the q-value algorithm, which was first presented by Storey (2002). q-
value requires that the prior knowledge of the null distribution of the test is known, such that the
p-values can be computed under the null density. In the case of distance covariance, Gretton et al.
(2008) proposed to fit a Gamma distribution as the null density, with the following parameters:
α =
E2(T )
V ar(T )
β =
V ar(T )
E(T )
, (3.8)
where T is defined as Eq. (3.5). Hence, the parameters in Eq. (3.8) can be estimated by the
distance covariance statistics, and the p-values are able to be computed from the Gamma ap-
proximation for the q-value method. The algorithm for the q-value method is as follows: first, for
each Ti, we compute the p-value pi under the Gamma approximation; we then compute q-values
q1, ..., qm for each test using the method of Storey (2003); by defining q˜ = argmaxi{qi 6 α},
we reject all tests with qi 6 q˜. Storey (2002) and Storey (2003) have showed that the q-value
algorithm (Algorithm 1) controls FDR under the desired α level. Note that step 2 of the above
algorithm is computed using the publicly available R-package qvalue.
The second algorithm uses local fdr (Eq. (5.1) in Efron et al. (2001b)) to control pFDR. In
Efron et al. (2001b)’s work, the null distribution is assumed either known or collected by permu-
tation. Here, we chose to use a Gamma approximation with empirical estimations of Eq. (3.8)
as the null density candidate for distance covariance statistics, and the detailed derivations are
presented in Section 2 of the supplementary materials. The following is a summary of Efron et al.
(2001b)’s work.
Algorithm 2:
Input: m hypotheses with statistics T1, ..., Tm in Eq. (3.5).
1. For each Ti, compute the p-value pi under the Gamma approximation.
2. For each pi, zi = Φ
−1(pi), for all i.
3. Estimate the parameters using a Gaussian mixture model (GMM) to the zi’s.
4. Compute local fdr as defined by Eq. (5.1) in Efron et al. (2001b).
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5. p̂FDR(z) is the conditional expectation of local fdr given z ∈ Γ.
6. Define z˜ = argmaxz{p̂FDR(z) 6 α}, and reject all tests with zi in rejection region. In
theory, this gives an pFDR no greater than α.
We now propose a new algorithm (denoted as local fdr modeling) for multiple testing adjust-
ment. The traditional multiple correction methods are based on p-values (e.g., algorithm 1 and
2), while our proposed method models the test statistics directly. The algorithm for the local fdr
modeling is similar to algorithm 2, but skipping the second step. This rule is similar to the one
proposed by Newton et al. (2003) in a different genomics setting, where more powerful inference
can be obtained by not mapping the test statistics from ti’s to zi’s.
Algorithm 3: (local fdr modeling):
Input: m hypotheses with statistics T1, ..., Tm in Eq. (3.5).
1. Fit a two-component mixture of Gammas to T1, ..., Tm.
2. Compute local fdr as defined by Eq. (5.1) in Efron et al. (2001b).
3. Define t˜ = argmaxt{p̂FDR(t) 6 α}, and reject all tests with ti > t˜. Where p̂FDR(t) is the
conditional expectation of local fdr given the rejection region.
4. Simulation study and real data analysis
We have implemented distance covariance in Matlab for our experiments. The R packages qvalue,
mixfdr, and mixtools were used for the multiple testing procedures. All the analyses were accom-
plished by using the university high performance computing cluster, which consists of 128 Intel
Xeon E5450 nodes, each with 8 cores and 32 GB of memory.
4.1 Simulation Design
To evaluate the methods described in Section 3, we simulated the data to examine the FDRs and
power estimates by controlling α at desired levels, and the settings of the simulation study were
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to mimic the structure of the genotypes and the phenotypes of the ADNI study. We considered
two types of correlations (i.e., the pure linear correlation, and the mixed linear and non-linear
correlations) and the impact of univariate and multivariate effects into three simulation settings.
For each setting, the samples were generated from a null and an alternative population, and 1000
genotypes were generated for multiple testing. Then, we examined the association one genotype
at a time across the 1000 genotypes for the following three settings. In this first case, we gen-
erated 50 paired samples: each pair included a single genotype and a phenotype, and followed a
bivariate Normal distribution, where the correlation coefficient ρ was 0.8 under the alternative or
around zero under the null. For the second and the third case, the sample size was 100, and the
univariate genotype was generated from N(0, 1) while the dimensions of phenotype were enlarged
to 30. The 100×30 phenotype data formed the mixed association effects between phenotypes and
the genotypes under the alternative, where the mixed associations were linear, exponential and
quadratic transformations (i.e., 10 duplicated copies of 100 genotypes; 10 exponential transfor-
mations of 100 genotypes; and 10 quadratic forms of 100 genotypes). For the null population, the
single genotype again was generated from N(0, 1) and the 30-dimensional phenotypes followed
a multivariate Normal with mean 0 and covariance matrix Σ, where Σ was independent in the
second simulation design and positive dependent (diagonal terms are one and off diagonal terms
are 0.5) on third case. The ratio between the null and alternative population was 19:1, and a
total of 1000 runs were repeated for each setting to assess the FDRs and power performances.
4.2 Simulation Results
Three FDR procedures were presented in Section 3.2, which we summarize again in the following:
Alg. 1: p-values (from Gamma approximation) + q-value method (Storey, 2003)
Alg. 2: p-values (from Gamma approximation) + local fdr method (Efron et al., 2001a)
Alg. 3: local fdr modeling proposed in Section 3.2
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Before the discussion of the FDRs and power estimates of three algorithms, we performed size
analysis to evaluate if a Gamma approximation (Gretton et al., 2008) is a proper null density for
algorithm 1 and 2. We generated 1000 (genotypes v.s. phenotypes) samples for the size analysis,
where the associations were all from the null population for the three simulation settings; 50 runs
were repeated to calculate the size. Table 2 reports the size estimates according to nominal values
from 0.1, 0.2,...,1, and the size estimates are very close to their corresponding nominal values for
all three simulations. Therefore, we concluded that the Gamma approximation is an appropriate
null distribution for the distance covariance statistic.
Table 3 shows the average FDRs, the average powers, and their standard errors at nominal
α levels 0.05, 0.1, 0.15 and 0.2 for the three simulations. The results show that the average
FDRs are all close or lower to the desired α values. The powers of algorithm 2 and 3 outperform
algorithm 1 for all α values; this implies the algorithms which utilize the local fdr method result
in powerful inference. In addition, the average estimated power of simulation 3 is smaller but
close to the power of simulation 2 at each level. This shows that the results of all multiple testing
adjusted algorithms are slightly affected by the noise of the dependent covariance structure, but
the overall performances are robust. Furthermore, the results of algorithm 2 and 3 are similar in
our simulation studies, and this suggests that algorithm 3 controls FDR well.
4.3 Application to ADNI data sets
We evaluated the three algorithms using the ADNI dataset. For each test, the independent
variable is a single SNP across the whole genome (448,244 SNPs). The multivariate response is a
119 dimensional vector (i.e. 119 ROIs), with each value corresponding to the average voxel value
for such brain region, based on the GSK CIC Atlas. We also considered the entire brain imaging
voxels (31,622 voxels) as another multivariate response for ADNI study, and the results are shown
in supplementary materials. In addition to the three algorithms described in Section 3.2, we also
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implemented a modified version of Stein et al. (2010a)’s work, in which they originally considered
simple linear regression (slr) as the association test between a single SNP and brain a voxel, with
our modification being a single SNP and a brain region. For this method, we selected the brain
region with the highest p-value at each SNP, then use the local fdr method to perform multiple
testing adjustment. This procedure is denoted as algorithm 4 (slr+local fdr method).
Table 4 displays the number of significant SNPs controlled by the α values from each algo-
rithm. Notice that there were 1180 significant SNPs with α at 0.5 in algorithm 4 (Stein et al.,
2010a), while algorithm 2 and 3 resulted in more than 20,000 findings, with algorithm 1 yielded
slightly above 5,000 SNPs at α level 0.05. In order to compare the inference information of the
significant SNPs in Table 4, the top 1180 SNPs were selected from each of the algorithm as the
input variables for disease status classification. Specifically, we performed binary disease status
classification (206 normal patients against 177 AD’s) due to the fact that AD is the definitive form
of the illness with much higher severity than MCI. We used LIBSVM (Chang and Lin, 2011) for
binary classification with leave-one-out to compute the prediction accuracy. The majority count
was 53.786%, and the prediction accuracy of top 1180 SNPs from algorithm 1, 2 and 3 were all
57.441%, as the top 1180 SNPs from the three algorithms were exactly the same. The prediction
accuracy of algorithm 4 was the same as the majority count. In addition, algorithms 1, 2 and 3 at
α level 0.05 found 5,388, 27,965, and 23,128 significant SNPs (table 4), and these SNPs yielded
57.964%, 62.141%, and 62.402% prediction accuracies, respectively. We have also performed the
functional annotation clustering analysis using DAVID v6.7 (DAVID, 2003). Table 5 lists the
top 8 clusters enrichment scores and the total enrichment scores. Since the top 1180 SNPs from
algorithms 1, 2 and 3 were identical, the enrichment scores from these three algorithms were also
the same, with each having a total score of 10.257 which is greater than the total enrichment
score of 5.739 from algorithm 4.
The above analyses imply that algorithm 4 (Stein et al., 2010a) yields less significant findings
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even with a higher nominal α level, and the 1180 SNPs contain less information in both disease
status classification and functional annotation clustering analysis. We further investigate the
functional enrichment terms of algorithm 2 and 3 at α level 0.05 in the region-wide study, and
the results are listed in supplementary materials.
5. Discussion and Conclusion
In this work, we have performed neuroimaging genomewide association studies using the ADNI
dataset. The proposed method using distance covariance is able to identify the dependencies
between the SNP variants and the brain volume differences, and utilize brain region interaction
effects at the same time. We also proposed a local fdr modeling strategy and compared the per-
formances with two existing multiple testing adjustment methods. The simulation studies showed
that p-values computed from Gamma approximation with the local fdr method (algorithm 2) and
local fdr modeling (algorithm 3) were able to control FDR at the proper levels. In the real data
application, the significant SNPs found by distance covariance contained more information than
simple linear regression (Stein et al., 2010a) in both disease status classification, and function
annotation clustering analysis. This is because simple linear regression only captures linear rela-
tionship between SNPs and brain MRI scans, while distance covariance is able to model non-linear
associations.
In addition to the distance covariance statistic in Eq. (3.3) that we have proposed for missing
data, another option to deal with the missing values is to impute the genotypes by assuming
the missing values are MAR. We used PLINK to impute the missing values in the ANDI study
under the assumption of MAR, as it is computationally efficient (Li et al., 2009). The PLINK
algorithm uses the standard EM algorithm and performs probabilistic estimation for each allele
combination based on the relatively small regions of genome for each individual (PLINK, 2007).
Based on the results of our PLINK imputation, the non-missing rate of the data increased from
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99.61% to 99.67%. Therefore, we work with the original datasets and assume MCAR. Explor-
ing combinations of imputation algorithms with distance covariance measures deserves further
investigation, but is beyond the scope of the paper.
There remain many open questions that could lead to important further developments. We
utilized distance covariance to measure the relationship between genetic variants and differences
in brain volumes in the first stage. This representation can be applied to capture the non-linear
dependencies between two sets of vectors with arbitrary dimensions, but it might also suffer a
possible bias when the number of dimensionality is much greater than the sample size (Cope,
2009). Therefore, we placed more emphasis of our results on the region-wide study in this work,
and we plan to study regularization approaches to the dependency measure to reduce this bias
in future work. It would also be desirable to develop distance covariance-type measures that
explicitly incorporate the discrete nature of the SNP data.
6. Supplementary Materials
The structure of supplementary materials is as follows: Section 1 lists the number of SNPs for
each chromosome, and Section 2 presents the details of algorithm 1, 2 and 3. The additional
analyses of the ADNI data are shown in Section 3.
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Fig. 1. Plots showing from left to right: Coronal, Sagittal and Axial views of GSK CIC Atlas, color coded
by the 119 region of interests.
Accept null Reject null Total
hypothesis hypothesis
Null true U V m0
Alternative true T S m1
W R m
Table 1. Summary of the possible outcomes for all m hypotheses.
Size Simulation 1 Simulation 2 Simulation 3
0.1 0.115 0.110 0.110
0.2 0.219 0.221 0.224
0.3 0.309 0.324 0.326
0.4 0.392 0.415 0.416
0.5 0.472 0.498 0.499
0.6 0.556 0.576 0.578
0.7 0.653 0.656 0.658
0.8 0.775 0.746 0.748
0.9 0.940 0.878 0.877
1.0 1.000 1.000 1.000
Table 2. The empirical size results from the three simulations for the size analysis.
2
2
R
E
F
E
R
E
N
C
E
S
Alg. 1: pvalues+qvalue Alg. 2: pvalues+local fdr Alg. 3: local fdr modeling
α FDR (s.e.) power (s.e.) FDR (s.e.) power (s.e.) FDR (s.e.) power (s.e.)
Simulation 1
0.05 0.000 (0.000) 0.000 (0.000) 0.019 (0.026) 0.882 (0.065) 0.039 (0.121) 0.904 (0.068)
0.10 0.006 (0.011) 0.691 (0.114) 0.063 (0.050) 0.964 (0.032) 0.080 (0.122) 0.965 (0.033)
0.15 0.007 (0.012) 0.777 (0.142) 0.121 (0.068) 0.985 (0.019) 0.128 (0.127) 0.984 (0.020)
0.20 0.028 (0.076) 0.900 (0.085) 0.186 (0.080) 0.993 (0.013) 0.184 (0.126) 0.990 (0.029)
Simulation 2
0.05 0.000 (0.000) 0.000 (0.000) 0.020 (0.026) 0.801 (0.106) 0.035 (0.044) 0.882 (0.087)
0.10 0.000 (0.000) 0.035 (0.026) 0.071 (0.051) 0.916 (0.085) 0.088 (0.061) 0.934 (0.038)
0.15 0.002 (0.007) 0.467 (0.175) 0.134 (0.070) 0.950 (0.064) 0.150 (0.075) 0.959 (0.025)
0.20 0.008 (0.016) 0.665 (0.159) 0.194 (0.080) 0.964 (0.048) 0.212 (0.082) 0.970 (0.016)
Simulation 3
0.05 0.000 (0.000) 0.000 (0.000) 0.017 (0.024) 0.758 (0.095) 0.030 (0.033) 0.844 (0.066)
0.10 0.000 (0.000) 0.020 (0.000) 0.064 (0.051) 0.899 (0.059) 0.084 (0.070) 0.918 (0.045)
0.15 0.002 (0.007) 0.418 (0.179) 0.126 (0.070) 0.944 (0.036) 0.145 (0.091) 0.951 (0.029)
0.20 0.004 (0.011) 0.572 (0.159) 0.194 (0.084) 0.963 (0.024) 0.208 (0.103) 0.965 (0.029)
Table 3. Simulation results of the average FDR estimates (with standard error) and the average power estimates (with standard error) of the three
algorithms described in Section 3.2. Simulation 1 is based on linear correlation; simulation 2 is based on mixed correlations with independent
covariance matrix; and simulation 3 is based on mixed correlations with dependent covariance matrix in Section 4.1.
R
E
F
E
R
E
N
C
E
S
2
3
α Alg. 1: pvalues+qvalue Alg. 2: pvalues+local fdr Alg. 3: local fdr modeling Alg. 4: slr+local fdr
0.05 5,388 27,965 23,128 0
0.10 8,447 34,659 29,288 18
0.15 11,041 39,875 34,261 38
0.20 13,804 44,604 38,794 95
0.30 19,299 53,716 47,535 275
0.40 25,537 63,449 56,853 612
0.50 448,073 75,030 68,365 1,180
Table 4. Number of significant SNPs found by the different algorithms with different α levels, under the region-wide study. The ADNI study was
used for this experiment.
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Top 1180 SNPs from each algorithm in table 4
Annotation cluster alg. 1a alg. 2b alg. 3c alg. 4d
1 3.167 3.167 3.167 1.479
2 1.680 1.680 1.680 1.332
3 1.198 1.198 1.198 1.040
4 1.157 1.157 1.157 0.775
5 1.014 1.014 1.014 0.508
6 0.947 0.947 0.947 0.261
7 0.572 0.572 0.572 0.175
8 0.523 0.523 0.523 0.169
total 10.257 10.257 10.257 5.739
Table 5. Enrichment scores for each cluster from DAVID database. a: top 1180 SNPs were selected from
5388 SNPs in algorithm 1 at level 0.05; b: top 1180 SNPs were collected from 27965 SNPs in algorithm 2
at level 0.05; and c: top 1180 SNPs were collected from 23128 SNPs in algorithm 3 at level 0.05; d: 1180
SNPs found at level 0.5 in algorithm 4.
